跳至主要内容
临床试验/IRCT2014020114333N17
IRCT2014020114333N17已完成未知

Comparison of anti-Mullerian hormone level in two treatment methods, myomectomy and uterine artery embolization, in patients with uterine fibroids

Kermanshah University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 40 years(—)
性别
Female

入选标准

  • age 25-40 years; having debilitating complaints such as severe bleeding due to myoma, uterine enlargement up to 16 weeks pregnancy, anemia and pressure on the pelvic organs of patients which candidates her for myomectomy.
  • Exclusion criteria: probability of pelvic malignancies, ovarian pathologies, pelvic infections; desiring fertility, contrast sensitivity, renal disorders, and systemic autoimmune disorders.

排除标准

  • 未提供

研究者

相似试验